The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Cannabidiol not effective in treatment-resistant schizophrenia

    Here is another in our ongoing series on recent marijuana-related medical research.

    Cannabidiol (CBD) is a major product of the marijuana plant. It lacks marijuana’s psychological effects, and it has been suggested that CBD might be effective as an antipsychotic. The aim of this study was to investigate the response to CBD in treatment-resistant schizophrenia.

    After 35 days of CBD treatment, one patient showed mild improvement, while two showed no improvement.

    There are several possible reasons for this.

    • Too few patents studied
    • Wrong dose
    • Too difficult to treat stage of the disease
    • Not treated long enough
    • It just doesn’t work

    As an aside, does it strike you as strange that a study of three patients has seven authors?

    8/31/06 22:13 JR

    Leave a Comment

    You must be logged in to post a comment.